Skip to main content

Emerging Tissue/Tumor-Agnostic Drugs to be a Chief Driver Fueling Global Liquid Biopsy Market Growth

According to Inkwood Research, the Global Liquid Biopsy Market is estimated to register a CAGR of 18.91% in terms of revenue during the forecasting years of 2021-2028.

“Browse 36 Market Data Tables and 67 Figures spread over 270 Pages, along with an in-depth TOC on the Global Liquid Biopsy Market Forecast 2021-2028.”

REQUEST FREE SAMPLE LINK - https://www.inkwoodresearch.com/reports/global-liquid-biopsy-market/#request-free-sample

VIEW TABLE OF CONTENT LINK - https://www.inkwoodresearch.com/reports/global-liquid-biopsy-market/#table-of-contents

BUY NOW- https://www.inkwoodresearch.com/reports/global-liquid-biopsy-market/

 

A liquid biopsy is a non-invasive approach, that helps detect and monitor cancer as well as other diseases. In order to perform a liquid biopsy, blood or other fluids like, urine, is collected, sequenced, and analyzed through next-generation sequencing (NGS) systems and assays. On account of its efficiency, tissue biopsy, an invasive procedure, is now being replaced by liquid biopsy. For instance, the method is also rapidly gaining traction as an alternative to tissue biopsy, for applications in transplant medicine, reproductive health, and cancer. 

Emerging Tissue/Tumor-Agnostic Drugs to Accelerate Market Growth

The emergence of tissue/tumor-agnostic drugs is an additional trend associated with liquid biopsy. It targets particular genetic variants within cancer and propels the use of liquid biopsy diagnostics for identifying the variations. The first instance of this phenomenon entails the expanded approval of Merck’s drug, Keytruda (pembrolizumab), in May 2017, for patients with metastatic cancer. Besides, it was also used for mismatch repair deficiency or microsatellite instability. Multiple other drug companies within the global liquid biopsy market are presently pursuing a similar approval strategy, emphasizing the genetic characteristics of cancer than the organ of origin.



To know more about this report, request a free sample copy. 

Treatment Selection is the Fastest-Growing Clinical Application

The selection of treatment plays a crucial role, in terms of disease treatment. Treatment selection also minimizes the disease’s drawbacks, thereby making the procedure more accurate and precise. Moreover, it helps physicians make more informed decisions while assisting patients, which in turn, ensures optimum treatment. In addition, the rising number of products specializing in treatment selection is observed across the global liquid biopsy market, for treating diverse cancer types, including, colorectal cancer, breast cancer, lung cancer, and others.

North America Dominated the Global Market in 2020

Key factors facilitating the liquid biopsy market growth in North America include the increasing rates of cancer, the growing preference towards non-invasive diagnostic technologies, the surging geriatric population, and the expanding prominence of companion diagnostics, across the region.

Since the global market is continually developing and emerging, customers often prefer trying popular products as it is convenient to shift from one product to another. However, owing to this factor, the loyalty of customers is endangered. As a result, the competition within the global liquid biopsy market is predicted to be medium to high.

Some of the distinguished players operating in the market are, Qiagen NV, Agilent Technologies Inc, Becton, Dickinson, and Company (BD), etc.

About Inkwood Research

Inkwood Research specializes in syndicated & customized research reports and consulting services. Market intelligence studies with relevant fact-based research are customized across industry verticals such as technology, automotive, chemicals, materials, healthcare, and energy, with an objective comprehension that acknowledges the business environments. Our geographical analysis comprises North & South America, CEE, CIS, Middle East, Europe, Asia, and Africa.

Contact Us

https://www.inkwoodresearch.com

sales@inkwoodresearch.com

+1 857-302-4704

Related Reports:

GLOBAL KIDNEY CANCER THERAPEUTICS AND DIAGNOSTICS MARKET

GLOBAL CANCER BIOMARKER MARKET FORECAST

GLOBAL BIOPSY DEVICE MARKET FORECAST

Labels:

Comments

Post a Comment

Popular posts from this blog

Surging Chronic Conditions to Supplement Global Magnetic Resonance Imaging (MRI) Systems Market Growth

Inkwood Research anticipates that the Global Magnetic Resonance Imaging (MRI) Systems Market is evaluated to record a CAGR of 5.50% in terms of revenue during the forecasted years of 2021-2028. “Browse 53 Market Data Tables and 48 Figures spread over 229 Pages, along with an in-depth TOC on the Global Magnetic Resonance Imaging (MRI) Systems Market Forecast 2021-2028.”   BUY NOW - https://www.inkwoodresearch.com/reports/mri-systems-market/   Magnetic resonance imaging (MRI) is characterized as a non-invasive imaging technology aiming to produce detailed 3-D (three-dimensional) anatomical images. It is typically used for the detection and diagnosis of diseases, in addition to monitoring further treatment. MRI systems are based on a sophisticated technology that detects changes in the rotational axis direction of protons found in water that constitutes living tissues. Increasing Prevalence of Chronic Conditions to Augment Market Growth The four most critical types of chron
Post a Comment
Read more

Global Pharmacy Automation Equipment Market to Register Notable Growth Given the Decentralization of Pharmacies

Inkwood Research anticipates that the Global Pharmacy Automation Equipment Market is evaluated to project a CAGR of 7.93% in terms of revenue during the forecasting years of 2021-2028. “Browse 39 Market Data Tables and 39 Figures spread over 200 Pages, along with an in-depth TOC on the Global Pharmacy Automation Equipment Market Forecast 2021-2028.”   To know more about this report, request a free sample copy. Pharmacy automation is characterized as decentralized or centralized automated dispensing, labeling, packing, and other systems, that help minimize dispensing errors. Moreover, it also plays a vital role in terms of improving the workflow efficiency of hospital nursing staff as well as pharmacies. Decentralization of Pharmacies to Augment Market Growth Decentralized pharmacy services are considered in order to refer to a practice model where a pharmacist located on the ward is primarily responsible for distribution and clinical services, including possibly order entry
Post a Comment
Read more

Development of Target Based Drug Drives the Global Protein Sequencing Market at 6.47%

According to a new market research report published by Inkwood Research, Global Protein Sequencing Market is estimated to project a CAGR of 6.47% during the forecasting years of 2020-2028. "Browse 39 Market Data Tables and 44 Figures spread over 147 Pages, along with an in-depth TOC on the Global Protein Sequencing Market Forecast 2020-2028.” REQUEST FREE SAMPLE LINK - https://www.inkwoodresearch.com/reports/protein-sequencing-market/#request-free-sample Protein sequencing provides information regarding the amino acids that constitute a protein. While the sequencing process is performed, amino acids are consecutively removed from the n-terminal end of the protein strand and identified in the order they occur in the protein. Growing Focus on Target-Based Drug Development Since the last few years, a growing number of findings based on proteomics have boosted innovative drug development. Moreover, many drugs have been developed with an emphasis on single protein target
Post a Comment
Read more